Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Gilead Sciences Inc. (GILD) shares rose 4.00% to $129.11 on a strong trading day, outperforming competitors like Johnson & Johnson (JNJ) and Abbott Laboratories (ABT). The stock reached a new 52-week high, surpassing its previous peak of $128.70. The S&P 500 Index and Dow Jones Industrial Average also saw gains of 1.16% and 1.21%, respectively, with Gilead's trading volume exceeding its 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments